Therefore, the incomplete blocking of checkpoint signaling due to the high prevalence of PD‐L2 expression in HNSCC might be one of the reasons for the lower toxicity of PD‐L1 inhibitors. Here, PDCD1LG2 is linked to head and neck squamous cell carcinoma.